Novel inhibition of cis/trans retinoic acid interconversion in biological fluids - An accurate method for determination of trans and 13-cis retinoic acid in biological fluids

Chao Jih Wang, Li Heng Pao, Cheng Huei Hsiong, Chih Yuan Wu, Jacqueline Jia Kang Whang-Peng, Oliver Yoa Pu Hu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25°C were studied. Our results showed that (1) the interconversion ratios (%) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150μM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000ng/ml) and 13-cRA (5-800ng/ml) in plasma showed good linearity (r 2=0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, %) for tRA and 13-cRA which were both less than 5.6%, (4) the mean recovery of the analytes were 78-94% for tRA and 80-92% for 13-cRA at concentration range from 1 to 1000ng/ml and 5 to 800ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45mg/m2 per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method.

Original languageEnglish
Pages (from-to)283-291
Number of pages9
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume796
Issue number2
DOIs
Publication statusPublished - Nov 5 2003
Externally publishedYes

Fingerprint

Isotretinoin
Tretinoin
Ethylmaleimide
Fluids
Ascorbic Acid
Plasmas
High Pressure Liquid Chromatography
Temperature
Pharmacokinetics
Calibration
Hepatocellular Carcinoma
Thermodynamic stability
Hot Temperature
Flow rate
Recovery

Keywords

  • Interconversion
  • Pharmacokinetics
  • Retinoic acid

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology

Cite this

@article{9c91b7e4bd424d8a99db2353ccc8a89e,
title = "Novel inhibition of cis/trans retinoic acid interconversion in biological fluids - An accurate method for determination of trans and 13-cis retinoic acid in biological fluids",
abstract = "All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25°C were studied. Our results showed that (1) the interconversion ratios ({\%}) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150μM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000ng/ml) and 13-cRA (5-800ng/ml) in plasma showed good linearity (r 2=0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, {\%}) for tRA and 13-cRA which were both less than 5.6{\%}, (4) the mean recovery of the analytes were 78-94{\%} for tRA and 80-92{\%} for 13-cRA at concentration range from 1 to 1000ng/ml and 5 to 800ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45mg/m2 per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method.",
keywords = "Interconversion, Pharmacokinetics, Retinoic acid",
author = "Wang, {Chao Jih} and Pao, {Li Heng} and Hsiong, {Cheng Huei} and Wu, {Chih Yuan} and Whang-Peng, {Jacqueline Jia Kang} and Hu, {Oliver Yoa Pu}",
year = "2003",
month = "11",
day = "5",
doi = "10.1016/S1570-0232(03)00572-5",
language = "English",
volume = "796",
pages = "283--291",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Novel inhibition of cis/trans retinoic acid interconversion in biological fluids - An accurate method for determination of trans and 13-cis retinoic acid in biological fluids

AU - Wang, Chao Jih

AU - Pao, Li Heng

AU - Hsiong, Cheng Huei

AU - Wu, Chih Yuan

AU - Whang-Peng, Jacqueline Jia Kang

AU - Hu, Oliver Yoa Pu

PY - 2003/11/5

Y1 - 2003/11/5

N2 - All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25°C were studied. Our results showed that (1) the interconversion ratios (%) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150μM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000ng/ml) and 13-cRA (5-800ng/ml) in plasma showed good linearity (r 2=0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, %) for tRA and 13-cRA which were both less than 5.6%, (4) the mean recovery of the analytes were 78-94% for tRA and 80-92% for 13-cRA at concentration range from 1 to 1000ng/ml and 5 to 800ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45mg/m2 per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method.

AB - All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25°C were studied. Our results showed that (1) the interconversion ratios (%) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150μM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000ng/ml) and 13-cRA (5-800ng/ml) in plasma showed good linearity (r 2=0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, %) for tRA and 13-cRA which were both less than 5.6%, (4) the mean recovery of the analytes were 78-94% for tRA and 80-92% for 13-cRA at concentration range from 1 to 1000ng/ml and 5 to 800ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45mg/m2 per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method.

KW - Interconversion

KW - Pharmacokinetics

KW - Retinoic acid

UR - http://www.scopus.com/inward/record.url?scp=0142227110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142227110&partnerID=8YFLogxK

U2 - 10.1016/S1570-0232(03)00572-5

DO - 10.1016/S1570-0232(03)00572-5

M3 - Article

C2 - 14581068

AN - SCOPUS:0142227110

VL - 796

SP - 283

EP - 291

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

IS - 2

ER -